<DOC>
	<DOCNO>NCT02435186</DOCNO>
	<brief_summary>The study objective investigate efficacy safety p53 combine chemotherapy ( cisplatin paclitaxel ) treatment recurrent Ovarian Epithelial Cancer , Fallopian Tube Cancer , Primary Peritoneal Cancer .</brief_summary>
	<brief_title>p53 Gene Treatment Recurrent Ovarian Epithelial Cancer , Fallopian Tube Cancer , Primary Peritoneal Cancer</brief_title>
	<detailed_description>The study objective investigate efficacy safety p53 combine chemotherapy ( cisplatin paclitaxel ) treatment recurrent Ovarian Epithelial Cancer , Fallopian Tube Cancer , Primary Peritoneal Cancer . study design : open-labeled , active control , randomize , phase 2 treatment : experiment group consist intraperitoneal p53 ( 2 x 10^12 viral particle ) plus cisplatin 150 mg/m^2 , Paclitaxel 175 mg/m^2 IV 3 h day 1 ; every 21 6 cycle . study end point : response rate , progression-free survival , overall survival Karnofsky scoreï¼ˆKPS ) .</detailed_description>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Fallopian Tube Neoplasms</mesh_term>
	<mesh_term>Peritoneal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1. histopathologically diagnosed ovarian epithelial cancer , fallopian tube cancer , primary peritoneal cancer 2. recurrent 3 . 18 year old 4. normal test hemogram , blood coagulation , liver kidney function 5. sign inform consent form . 1 . Serious blood coagulation disorder , bleed tendency , platelet &lt; 6 * 1000000000/L ; 2. serious heart , lung function abnormality severe diabetes patient ; 3. active infection ; 4. severe atherosclerosis ; 5 . AIDS patient ; 6. serious thrombotic embolic event within 6 month ; 7. renal insufficiency require hemodialysis peritoneal dialysis ; 8. pregnant lactate woman ; 9. mental disorder disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>p53 gene</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>recurrent</keyword>
	<keyword>epithelial</keyword>
	<keyword>ovarian cancer</keyword>
	<keyword>fallopian tube cancer</keyword>
	<keyword>primary peritoneal cancer</keyword>
</DOC>